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Linkage disequilibrium (LD) is a proven tool for evaluating population structure and localizing genes for
monogenic disorders. LD-based methods may also help localize genes for complex traits. We evaluated
marker–marker LD using 43 microsatellite markers spanning chromosome 20 with an average density of 2.3 cM.
We studied 837 individuals affected with type 2 diabetes and 386 mostly unaffected spouse controls. A test of
homogeneity between the affected individuals and their spouses showed no difference, allowing the 1223
individuals to be analyzed together. Significant (P < 0.01) LD was observed using a likelihood ratio test in all
(11/11) marker pairs within 1 cM, 78% (25/32) of pairs 1–3 cM apart, and 39% (7/18) of pairs 3–4 cM apart, but
for only 12 of 842 pairs more than 4 cM apart. We used the human genome project working draft sequence to
estimate kilobase (kb) intermarker distances, and observed highly significant LD (P < 10−10) for all six marker
pairs up to 350 kb apart, although the correlation of LD with cM is slightly better than the correlation with
megabases. These data suggest that microsatellites present at 1-cM density are sufficient to observe
marker–marker LD in the Finnish population.
Linkage disequilibrium (LD), the nonrandom association be-
tween alleles of linked markers, reflects the size of chromo-
somal segments remaining intact in a population. LD analysis
has proved powerful for high-resolution mapping of disease
genes for monogenic disorders, including cystic fibrosis (Rom-
mens et al. 1989) and diastrophic dysplasia (Hastbacka et al.
1994). In the Finnish population, LD has narrowed the can-
didate gene interval for many recessive disorders that have
one or a few predisposing alleles at a single locus (Peltonen et
al. 1999).
In principle, LD also may aid in positional cloning of
genes for complex traits in founder populations, particularly
if one or a small number of founder alleles contributes sub-
stantially to disease risk, and if the density of markers is suf-
ficiently high. Marker–marker LD may provide an upper
bound for the needed marker density by demonstrating the
presence of chromosomal regions inherited together since the
population was founded or subjected to a bottleneck.
The limited available experimental data report varying
evidence of LD over cM distances. In one study of 50 Finns, up
to one half of the marker pairs within 2 cM showed LD at P <
0.05 (Peterson et al. 1995). However, a study of the X chro-
mosome in 80 Finnish males reported that only 2 of 16
marker pairs up to 2 cM apart showed significant LD (P < 0.05)
(Laan and Paabo 1997). On chromosomes 5, 6, and 8, in an
average of 986 haplotypes from Irish schizophrenia pedigrees,
significant LD (P < 0.05) was observed in 81% of marker pairs
within 1 cM and 35% of pairs 1 to 2 cM apart (Kendler et al.
1999). A genome-wide survey of LD performed with 5048 mi-
crosatellites in 54 independent chromosomes from European,
Utah, and Amish CEPH families detected significant (P < 0.01)
LD in ∼4% of markers within 4 cM of one another (Huttley et
al. 1999). Recently, Eaves et al. assessed LD in a 6.5-cM region
of chromosome 18q21 in samples of 800 chromosomes each
from Finland, Sardinia, the United States, and the United
Kingdom (Eaves et al. 2000). They found LD extending up to
1 cM, with somewhat greater LD in the Finns and Sardinians.
Additional data are needed in various populations and ge-
nomic regions to estimate the extent and variability of LD and
to assess whether the presence of LD will be useful for fine-
mapping complex disease genes.
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Type 2 diabetes is a common disorder that causes con-
siderable morbidity and mortality throughout the world. Evi-
dence for a genetic component in type 2 diabetes has been
obtained using twin and family history studies (Newman et
al. 1987; Rich 1990; Kaprio et al. 1992). Several groups have
identified linkage signals for type 2 diabetes affection status
(Ehm et al. 2000), and one underlying gene has been identi-
fied (Horikawa et al. 2000). The Finland–United States Inves-
tigation of NIDDM Genetics (FUSION) study aims to identify
susceptibility genes for type 2 diabetes and related quantita-
tive traits in the Finnish population. In this study, we ascer-
tained type 2 diabetes-affected sibling pairs and additional
relatives (Valle et al. 1998). A 10-cM genome scan on >2000
individuals revealed several regions of suggested affected sib-
pair linkage (Ghosh et al. 2000), including portions of both
arms of chromosome 20 (Ghosh et al. 1999). To better assess
the importance of these regions, we genotyped a total of 43
markers at 2.3 cM average density on this chromosome. These
data provide the opportunity to assess the degree of marker–
marker LD and the distances over which LD extends. We pre-
sent here microsatellite marker-to-marker LD across chromo-
some 20 in 1223 individuals. We show that significant inter-
marker LD is virtually always observed for marker pairs up to
1 cM apart, and is generally absent for marker pairs at dis-
tances greater than 4 cM apart.
RESULTS
Forty-three microsatellite markers spanning chromosome 20
were genotyped on 837 unrelated Finns affected with type 2
diabetes and 386 of their spouses. Estimated genetic positions
of the markers are shown in Table 1. The 43 markers have an
average estimated heterozygosity of 0.77 and average spacing
of 2.3 cM across the 99.2-cM chromosome. Table 1 also shows
the number of alleles we observed for each marker and the
number of alleles we analyzed when low-frequency alleles
were pooled.
To determine if the affected individuals and their spouses
showed different haplotype frequencies, a permutation test of
heterogeneity was performed for all 903 possible pairs of the
43 markers. Among these pairs, 12 were significant at the 0.01
level, consistent with randomness. Further, the distribution
of the 903 P-values appeared to be uniform across the interval
zero to 1 (data not shown). These results suggested no impor-
tant differences in haplotype frequencies exist between the
affected individuals and controls, allowing us to pool data
across the two samples.
After pooling the diabetic individuals and their spouses
to generate a sample of 1223 individuals, we analyzed all 903
possible marker pairs using a likelihood ratio test for LD. We
plotted the log10 P-values of all 903 comparisons in the
combined sample as a function of estimated intermarker dis-
tance (Fig. 1a). A total of 55 marker pairs are significant at the
0.01 level (log10 P-value of 2), compared to nine significant
results expected by chance in the absence of LD. LD between
marker pairs less than 10 cM apart are shown in greater detail
(Fig. 1b). We observed significant LD between all marker pairs
within 1 cM, 78% between 1 and 2 cM, 79% between 2 and 3
cM, and 39% between 3 and 4 cM (Table 2). Only 1.4% (12/
842) of marker pairs greater than 4 cM apart show significant
LD at the 0.01 level, slightly greater than that expected by
chance alone.
We also measured LD using a D statistic modified for
multiallelic markers (Hedrick 1987). The rise in D values for
intermarker distances up to 4 cM is similar to the likelihood
ratio P-values (Fig. 2). Importantly, this modified D statistic is
inversely related to sample size, as can be observed by com-
paring samples of 386 spouse controls and 837 affecteds to the
combined sample. For distant marker pairs not expected to
exhibit LD, the multiallelic D statistic approaches asymptotes
that are larger for smaller samples (Fig. 2).
The extent of LD depends on recombination rather than
physical intermarker distance, although the presence of LD
over kilobase distances can be used during positional cloning
studies to determine the marker density needed to detect LD.
We used finished and unfinished genomic sequence to esti-
mate the physical distances between our markers. We evalu-
ated the presence of significant LD for all 903 possible pairs of
43 markers, and show marker pairs up to 10 megabases (Mb)








S103 0.0 0.70 8 5
S117 0.5 0.87 15 8
S906 5.1 0.78 12 6
S193 9.1 0.72 13 4
S889 10.0 0.82 19 8
S482 11.8 0.69 9 4
S849 14.8 0.69 17 5
S905 18.6 0.64 11 4
S892 20.6 0.86 12 8
S846 20.6 0.73 10 5
S115 22.1 0.64 7 4
S851 25.5 0.76 14 6
S917 26.2 0.87 16 8
S894 30.4 0.83 12 7
S189 32.4 0.69 10 6
S898 37.3 0.74 18 5
S114 42.7 0.83 11 7
S912 48.2 0.83 12 7
S477 48.9 0.74 11 5
S874 52.1 0.79 16 6
S195 52.7 0.85 16 7
S909 53.4 0.70 16 5
S107 58.1 0.84 15 6
S170 59.6 0.80 17 8
S96 62.4 0.82 13 7
S119 65.7 0.80 10 6
S481 65.9 0.83 13 8
S836 66.9 0.83 12 7
S888 67.7 0.90 20 8
S886 68.1 0.86 10 7
S197 69.1 0.75 11 6
S178 70.2 0.78 11 7
S866 71.8 0.85 19 8
S196 74.5 0.79 23 4
S857 76.3 0.84 13 8
S480 79.2 0.75 11 6
S840 80.2 0.80 18 7
S211 80.2 0.65 13 5
S120 83.2 0.83 18 7
S100 85.8 0.74 12 5
S102 87.7 0.44 5 4
S171 96.1 0.80 13 6
S173 99.2 0.73 13 7
H, Heterozygosity.
aNumber of alleles observed in an average of 5114 individuals per
marker, typed as part of the FUSION study.





apart (Fig. 3). Significant LD at the 0.01 level is observed for
69% (20/29) of markers up to 1 Mb apart, 51% (18/35) be-
tween 1 and 2 Mb apart, 12% (4/33) between 2 and 3 Mb
apart, and 6% (2/36) between 3 and 4 Mb apart. Only 1.4%
(11/770) of markers greater than 4 Mb apart showed signifi-
cant LD. Strongly significant LD (P < 1010) was observed for
all six marker pairs up to 350 kb apart, and 75% (9/12) for
pairs up to 500 kb apart. As expected, the correlation between
LD and physical distance (Spearman rank correlation r =
0.56) is less strong than with genetic distance (r = 0.63)
for markers up to 10 cM apart.
DISCUSSION
We analyzed marker–marker LD
across all of chromosome 20 using a
large sample of 1223 unrelated
Finnish subjects. We observed sig-
nificant (P < 0.01) marker–marker
LD for all marker pairs within 1 cM
of each other and continued el-
evated LD for distances up to 4 cM
(Fig. 1). We obtained similar con-
clusions when analyzing the data
based on significance level 0.001
(Table 2) or 0.05 (Fig. 1). We ob-
served significant LD (P < 0.01) at
estimated physical distances up to 4
Mb, with strongly significant LD (P
< 1010) at distances up to 350 kb.
We did not detect regions of chro-
mosome 20 that exhibited obvi-
ously higher or lower LD (data not
shown), although the variable spac-
ing of our markers did not provide
ideal data to address this issue.
Our findings of significant LD
cannot be compared directly to re-
sults obtained from most other
studies using microsatellite markers
because the likelihood ratio test is
strongly affected by sample size. In
particular, our large sample size en-
ables quite sensitive detection of
LD. The expected value of the like-
lihood ratio statistic is proportional
to sample size, while P-values are af-
fected even more strongly by
sample size. This characteristic is
consistent with the smaller number
of significant marker pairs observed
in the smaller sample of 386
spouses (Table 2).
The likelihood ratio statistic
shown here detects the presence
but does not evaluate the strength
of LD. To measure the strength of
LD and to compare our data with a
recent report (Eaves et al. 2000), we
computed a multiallelic extension
of the D statistic (Fig. 2). Although
this statistic is valid for the pub-
lished comparison of samples with
the same size that was typed using
the same markers, we realized that
the statistic is not valid for comparison with our data because
it is strongly affected by sample size and allele frequencies. In
general, smaller sample sizes show larger multiallelic D val-
ues. At intermarker distances well beyond those where we
would reasonably observe LD, we would expect the multial-
lelic D values of different sized samples to approach the same
asymptote. However, multiallelic D values in our sample of
386 individuals approached an asymptote almost twice as
large as that observed for 1223 individuals. We also investi-
gated a recently reported statistic (Zhao et al. 1999) that has
the advantage of providing a quantity that appears near mean
Figure 1 Presence of LD on chromosome 20 in 1223 Finns. log10(P-values) for a likelihood ratio
statistic, limited at 1010. Each point represents one pair of markers; (a) all 903 possible pairs of 43
markers, (b) 168 pairs of markers <10 cM apart.
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zero under the null hypothesis of linkage equilibrium; how-
ever, the variance of this statistic still depends on sample size.
We are not aware of a good summary measure that enables
accurate comparison of LD between studies that use different
sample sizes and markers with differing numbers of alleles
and differing allele frequencies.
We have previously reported evidence for linkage to type
2 diabetes on chromosome 20 in our Finnish sample (Ghosh
et al. 1999). For LD analysis, one might expect heterogeneity
when combining case and control samples. This would likely
be true for a simple Mendelian disease in the region of the
disease locus. However, for a complex disorder such as type 2
diabetes where a particular susceptibility variant alone likely
has only limited independent impact on disease risk, we
would expect little effect of susceptibility variants on LD
along the chromosome. Thus, the similar extent of LD among
individuals affected with diabetes compared to spouse con-
trols (Table 2) and the homogeneity of haplotype frequency
estimates between these groups is not surprising.
LD may depend on population substructure, which may
be advantageous in the search for genes conferring suscepti-
bility to a complex trait such as diabetes. Rare disease alleles in
families from the north and east of Finland travel on haplo-
types as large as 15 cM (de la Chapelle and Wright 1998),
suggesting that it may be possible to identify diabetes-
associated haplotypes in similar geographic subsets. Yet a re-
cent study found no difference between LD in 50 males from
southwestern and eastern regions of Finland, founded ∼2000
and ∼400 years ago, respectively (Jorde et al. 2000). Two re-
cent reports detected only modestly increased LD for the iso-
lated Finnish and Sardinian populations compared to other
European or American samples for microsatellites (Eaves et al.
2000) and single nucleotide polymorphisms (SNPs) (Taillon-
Miller et al. 2000), respectively. Additional comparative data
will help clarify whether LD is increased in various founder
populations, enabling LD to be detected using smaller sample
sizes or a lower density of markers.
Althoughmethods to genotype SNPs are becoming easier
and more accessible (Chen et al. 1998; Ryan et al. 1999; Grif-
fin and Smith 2000), a high-density map of microsatellite
markers remains extremely useful for studies of complex
traits. The presence of multiple alleles allows haplotypes to be
inferred more easily, generating more power to detect LD,
although microsatellite marker mutation breaks down con-
served haplotypes, and can also reduce the extent of LD. A
significant challenge for assessing LD with microsatellite
markers is the difficulty in generalizing LD statistics to mul-
tiple alleles, as described above.
We evaluated marker-to-marker LD as part of our inves-
tigation of disease variant-to-marker LD. Ideally, a threshold
level of LD obtained between neighboring markers would in-
dicate that the interval had been effectively scanned for an
associated disease variant, although whether such a threshold
Figure 2 Strength of LD on chromosome 20 in 1223 Finns. Mul-
tiallelic D statistic for 386 spouses (open triangles), 837 individuals
with type 2 diabetes (shaded squares), and the combined sample of
1223 (black circles). Each point represents 10 marker pairs, and is
plotted at the mean intermarker distance for those pairs.
Figure 3 LD versus physical distance. log10(P-values) for a likeli-
hood ratio statistic, limited at 1010. Each point represents one pair of
markers. Two hundren ninety marker pairs up to 10 Mb apart are
shown.
Table 2. Number of Marker Pairs in LD
Intermarker
distance (cM) n
P < 0.01 P < 0.001
spouses affecteds combined spouses affecteds combined
<1 cM 11 11 11 11 10 11 11
1–2 cM 18 9 13 14 7 10 12
2–3 cM 14 2 8 11 1 4 7
3–4 cM 18 4 6 7 1 2 4
4 cM 842 17 16 12 0 3 4
Total in 99.2 903 43 54 55 19 30 38
P-values from a likelihood ratio test for LD. n, number of marker pairs. The spouse, affected, and combined samples




can be found remains unclear. It seems highly likely that an
interval lacking significant marker-to-marker LD has not yet
been scanned thoroughly. Thus, to proceed with fine-
mapping of a type 2 diabetes susceptibility gene on chromo-
some 20, we will add markers to regions where less marker-
to-marker LD is observed while searching for alleles or haplo-
types associated with disease. Additional empirical data are
needed to determine the marker density required for associa-
tion studies of complex diseases.
METHODS
Sample
The FUSION study design and first phase of sample recruit-
ment have been described previously (Valle et al. 1998).
Briefly, we sampled 580 families ascertained through a type 2
diabetes-affected sibling pair, and collected additional af-
fected and unaffected relatives. A second cohort includes ad-
ditional family members as well as a separate set of 275 fami-
lies. All individuals studied are believed to be of Finnish heri-
tage based on their birthplaces and their grandparents’
birthplaces within Finland. In this report we used genotype
data from 837 unrelated affected individuals and 386 unre-
lated spouses. Two hundred six of these spouses tested unaf-
fected by oral glucose tolerance test (OGTT) in our study, 160
reported themselves to be unaffected, and 20 had an un-
known phenotype.
Markers
We selected 43 microsatellite markers, including 39 dinucleo-
tide and 4 tetranucleotide repeats, from chromosome 20maps
and genotyped them as previously described (Ghosh et al.
1997). We estimated heterozygosities and the number of al-
leles from an average of 1142 unrelated individuals per
marker. These heterozygosities are very similar to those we
reported previously (Ghosh et al. 1999), but differ slightly
because we analyzed an expanded sample. Data for all mark-
ers are consistent with Hardy-Weinberg equilibrium.
Maps
We estimated sex-averaged genetic maps from combined data
on 983 individuals in 205 FUSION-extended families and
from cleaned genotypes of CEPH pedigrees (Broman et al.
1998). The genetic map used in these analyses differs slightly
from a previously reported map (Ghosh et al. 1999) because
additional FUSION data have now been incorporated. This
marker order is consistent with the available mapping data
produced by the Chromosome 20 Mapping Group at the
Sanger Centre, and were obtained from the World Wide Web
at http://www.sanger.ac.uk/HGP/Chr20/.
We estimated a physical map using chromosome 20
clone sequences available from the Sanger Centre and Gen-
Bank as of October 30, 2000. Most sequence data were pro-
duced by the human Chromosome 20 Sequencing Group at
the Sanger Centre, and can be obtained from ftp://
ftp.sanger.ac.uk/pub/human/chr20/. Other data were ob-
tained from GenBank ftp://ncbi.nlm.nih.gov/genbank/
genomes/H_sapiens/CHR_20/. We determined the nucleotide
positions of our markers on individual clones using electronic
PCR and BLAST(http://www.ncbi.nlm.nih.gov/), and used an
unpublished clone order (P. Deloukas, pers. comm.) to gen-
erate a contiguous map. We assumed the size of six contig
gaps to be 100 kb each, and the size of 12 unfinished BACs to
be their current sequence length. We also assumed that 100
nucleotides of each clone overlaps the adjacent clone, and
that all finished clones are numbered according to their ori-
entation on the chromosome. The resulting physical map,
which starts at marker D20S103 and ends at marker D20S173,
is 59 Mb long.
Tests of Linkage Equilibrium between Pairs
of Markers
We formed 903 = (43*42)/2 marker pairs by considering all
possible pairs of the 43 microsatellite markers. For each
marker pair, we performed joint analyses for the 837 diabetic
individuals and their 386 spouse controls. Maximum likeli-
hood estimates for allele frequencies were obtained for each of
the 43 markers by allele counting. Maximum likelihood esti-
mates of haplotype frequencies for the 903 marker pairs were
obtained by employing the expectation-maximization (E-M)
algorithm. We used a likelihood ratio statistic to test for LD.
This statistic compared the maximum probability of the ob-
served sample of genotypes allowing for LD (based on esti-
mates of haplotype frequencies) to the maximum probability
of the observed sample assuming linkage equilibrium (based
on estimates of haplotype frequencies calculated as products
of the relevant allele frequency estimates). The distribution of
2 times the natural logarithm of this likelihood ratio is as-
ymptotically distributed as 2, with degrees of freedom equal
to (n11)(n21), where n1 was the number of alleles used for
the first marker, and n2 was the number of alleles used for the
second marker. To reduce the effects of rare alleles and to
preserve the power to reject the null hypothesis of linkage
equilibrium by limiting the degrees of freedom of the test
statistic, we pooled alleles with frequencies less than 0.05.
Prior to pooling the data from the affected individuals
and their spouses, we carried out a likelihood ratio test of
homogeneity of haplotype frequencies for each pair of mark-
ers. For this test we estimated the haplotype frequencies sepa-
rately for the affected individuals and their spouses using the
E-M algorithm. The likelihood ratio statistic compared the
product of the maximum likelihoods for the two samples to
the maximum likelihood for the two samples analyzed
jointly. Again, alleles with frequencies <0.05 in the joint
sample were pooled. Because of small estimated haplotype
frequencies, we assessed significance levels using a permuta-
tion test. For each of the 903 marker pairs, we generated 100
replicate samples by permutation. To construct these per-
muted samples, we randomly permuted affection status of the
1223 individuals, keeping the marker data the same. For each
permuted sample, we calculated the likelihood ratio test for
homogeneity of haplotype frequencies. Based on the 100 per-
muted samples for a marker pair, we estimated the P-value in
the test for homogeneity of haplotype frequencies as the pro-
portion of permuted-data statistics greater than the observed-
data statistic.
To measure the strength of disequilibrium, we used
Lewontin’s D (Lewontin 1964) modified for multiple alleles
(Hedrick 1987). For two-allele markers, D is the standardized
disequilibrium value that takes the usual disequilibrium coef-
ficient P(AiBj)  P(Ai)P(Bj) and divides it by its maximal pos-
sible value. Given multiple alleles, we calculate the weighted
average of the D values where the weights are the products of
the corresponding allele frequencies. That is,
D = i j pi qj |Dij|,
where pi and qj are allele frequencies at the two loci of inter-
est, and Dij is the standardized disequilibrium coefficient
based on alleles Ai and Bj.
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